With the first half of 2019 to pass soon, according to Xanda Data V3.5 (Xanda.cn) on the products approved by NMPA, imported new drugs are based on clinically imperative marketed drugs, and approvals of generic drugs are being accelerated.
Date:2019-07-12 Views:515
With the first half of 2019 to pass soon, according to Xanda Data V3.5 (Xanda.cn) on the products approved by NMPA, imported new drugs are based on clinically imperative marketed drugs, and approvals of generic drugs are being accelerated.
